research-article
Heart Transplant Biopsies: Interpretation and Significance
1 University of toronto, Mcmaster University, Canada;
2 University of Toronto, Canada
Correspondence to: Jagdish Butany, PATHOLOGY, University of Toronto/University Health Network, University of Toronto/University Health Network, Department of Pathology, Toronto General Hospital, Toronto, /M5G 2C4, Canada; jagdish.butany{at}uhn.on.ca
Accepted October 7, 2009
Endomyocardial biopsy (EMB) is the gold standard for monitoring the graft heart following orthotopic heart transplantation. An established modality for the diagnosis of cardiac disease, the EMB has gained increasing "popularity" as the standard for monitoring patients post cardiac transplant.1,2 At most centres, patients undergo regularly scheduled biopsies, performed every week initially and then every three months for the rest of the patients life. The analysis and diagnosis of EMB based graft rejection is critical for the appropriate and timely modulation of immunosuppression protocols.
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
